Theodore Yanagihara, MD, PhD
Basic profileUniversity of North Carolina at Chapel Hill
Theodore Yanagihara is an Oncology physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 8 publications with 529 citations (h-index 3); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
101 Manning Dr # 7512
Chapel Hill, NC 275144220
Telephone
336-623-9713Provider last certified this registry record 29 Mar 2021.
Clinical trials
- GRID Therapy for Extremity Soft Tissue Sarcoma
Sponsor: UNC Lineberger Comprehensive Cancer Center
- Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
Sponsor: UNC Lineberger Comprehensive Cancer Center
- PROs Following Low-dose Irradiation for Osteoarthritis
Sponsor: University of North Carolina, Chapel Hill
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- HISTOSONICS, INC.Program year20251 payment
- Janssen Biotech, Inc.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Gonadotropin Releasing Hormone Receptor Antagonist100%Orgovyx100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Timing of Planning Magnetic Resonance Imaging and Patient Selection for Adaptive Radiation Therapy in Newly Diagnosed High-Grade Glioma
International Journal of Radiation Oncology*Biology*Physics
2025 - The Peaks and Valleys of Photon Versus Proton Spatially Fractionated Radiotherapy
Seminars in Radiation Oncology
2024 - Association between tumor location and toxicity outcomes after stereotactic radiosurgery for brain metastases
Journal of Neuro-Oncology
2024 - Diffusion-weighted imaging of the brain for glioblastoma: Implications for radiation oncology
Applied Radiation Oncology
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”